Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?

@article{Cicconi2007IsTI,
  title={Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?},
  author={Paola Cicconi and A. Cozzi-lepri and Andrew Phillips and Massimo Puoti and Giorgio Antonucci and Paolo Emilio Manconi and Giulia Tositti and Vincenzo Colangeli and Miriam Lichtner and Antonella d'Arminio Monforte},
  journal={AIDS},
  year={2007},
  volume={21 5},
  pages={599-606}
}
OBJECTIVES To investigate if the risk of liver enzyme elevation (LEE) in HIV/hepatitis B or C (HBV, HCV) co-infection is altered by HAART (two or more drugs). METHODS Analysis comprised HIV-positive patients in the ICoNA study without acute hepatitis who had >or= 1 positive HCV antibody test and > 1 positive HBV surface antigen test. LEE was defined as > 5x baseline alanine aminotransferase (ALT) or > 3.5x baseline if the baseline was > 40 IU/l. Analysis used Poisson regression with… CONTINUE READING
17 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

Similar Papers

Loading similar papers…